CEACAM5

By Targets:	ADC Antibody (2) Antibody-Drug Conjugates (ADCs) (3) Microtubule/Tubulin (1) Radionuclide-Drug Conjugates (RDCs) (1) Small Interfering RNA (siRNA) (2) Topoisomerase (1) Transmembrane Glycoprotein (10)
By Research Areas:	Cancer (11) Inflammation/Immunology (3)
Oligonucleotides:	Mouse Pre-designed siRNA Sets (1) Human Pre-designed siRNA Sets (1) siRNAs (2)

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-P99054

Tusamitamab SAR-408377; PF-08046050 Antibody; SAR445953 Antibody	Transmembrane Glycoprotein ADC Antibody	Cancer
Tusamitamab is an IgG1 monoclonal antibody that targets *CEACAM5*. Tusamitamab can be used to synthesize ADC Tusamitamab ravtansine (SAR408701) (HY-P99542) .

HY-P99542

Tusamitamab ravtansine SAR-408701; HuMAb2-3-SPDB-DM4	Antibody-Drug Conjugates (ADCs) Microtubule/Tubulin	Cancer
Tusamitamab ravtansine (SAR-408701) is a targeted ADC against tumor cells expressing *CEACAM5, composed of a humanized anti-CEACAM5* monoclonal antibody covalently linked to the potent cytotoxic agent, maytansinoid DM4 (HY-12454), via a cleavable linker. Tusamitamab ravtansine has an average drug-to-antibody ratio (DAR) of 3.8 .

HY-177434

Precemtabart tocentecan Precem-TcT; M 9140	Antibody-Drug Conjugates (ADCs) Transmembrane Glycoprotein Topoisomerase	Cancer
Precemtabart tocentecan (Precem-TcT; M 9140) is an anti-CEACAM5 (carcinoembryonic antigen-related cell adhesion molecule 5) antibody-drug conjugate (ADC). Precemtabart tocentecan consists of a tumor-specific anti-CEACAM5 monoclonal antibody Precemtabart (HY-P990940), a highly hydrophilic and stable cleavable β-glucuronide linker, and a topoisomerase 1 inhibitor payload Exatecan (HY-13631), and the drug-linker conjugate for ADC is Mal-Gly-PAB-Exatecan-D-glucuronic acid (HY-153179). Precemtabart tocentecan inhibits the growth of CEACAM5-positive cancer cells. Precemtabart tocentecan exhibits significant antitumor activity in CEACAM5-expressing xenograft models. Precemtabart tocentecan can be used for the study of CEACAM5-expressing advanced solid tumors, especially mCRC .

HY-164899

2A3 2-aminopyridine-3-carboxylic acid imidazolide	Transmembrane Glycoprotein	Cancer
2A3 (2-aminopyridine-3-carboxylic acid imidazolide) is a T cell activator that specifically binds to *CEACAM6* and *CEACAM5. 2A3 exhibits enzymatic activity that catalyzes the glucuronidation of specific substrates (e.g., 1-naphthol), and possesses significant cytotoxic activity. When integrated into CAR T cells or used alone, 2A3 acts by inducing cytokine release, degranulation, and direct cytotoxicity. 2A3 kills pancreatic and breast cancer cells with high target antigen expression in vitro, and significantly inhibits the growth of pancreatic cancer xenografts in vivo. 2A3 broadly targets malignant tumors with overexpressed CEACAM5, CEACAM*6, or co-expressed both, and shows high expression mainly in tissues such as the liver and colon. 2A3 serves as an important research tool for the immunotherapy of pancreatic and breast cancer . 2A3 is a novel SHAPE reagent, which can be used for the analysis of RNA structure both in vitro and in vivo . 2A3 is an electrophilic chemical probe that acylates the 2'-OH in the RNA backbone. 2A3 can be used for RNA SHAPE-MaP experiments and is capable of analyzing the RNA secondary structures at single nucleotide resolution.

HY-P99681

Labetuzumab govitecan IMMU 130; hMN-14-SN-38	Antibody-Drug Conjugates (ADCs)	Cancer
Labetuzumab govitecan (IMMU 130) is an Anti-CEACAM5/SN-38 antibody-drug conjugate (ADC). Labetuzumab govitecan consists of the antibody Labetuzumab, SN-38, and a pH-sensitive Linker. Labetuzumab govitecan can be used for research of cancers, such as colorectal cancer .

HY-P991060

Cergutuzumab	Transmembrane Glycoprotein	Cancer
Cergutuzumab is a fully human IgG1 antibody that targets carcinoembryonic antigen (CEA, *CEACAM5, CD66e*). Cergutuzumab can be used to form the recombinant protein Cergutuzumab amunaleukin (HY-P99498) .

HY-RS02441

CEACAM5 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
CEACAM5 Human Pre-designed siRNA Set A contains three designed siRNAs for CEACAM5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CEACAM5 Human Pre-designed siRNA Set A CEACAM5 Human Pre-designed siRNA Set A

HY-P991469

AMG-211 MEDI-565	Transmembrane Glycoprotein	Cancer
AMG-211 (MEDI-565)i s a bispecific antibody targeting CD3E and *CEACAM5/CEA/CD66e*. AMG-211 can be used in Gastrointestinal cancer and Solid tumours research .

HY-P990853

*Anti-CEACAM5* Antibody (4H11-8)**	Transmembrane Glycoprotein	Cancer
Anti-CEACAM5 Antibody (4H11-8) is a kind of mouse IgG1 κ chimeric antibody, targeting to human *CEACAM5. Anti-CEACAM5* Antibody (4H11-8) reacts with human CEACAM5 (carcinoembryonic antigen-related cell adhesion molecule 5). Anti-CEACAM5 Antibody (4H11-8) can be used for detecting CEACAM5 in cancer.

HY-RS17043

Ceacam5 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Ceacam5 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ceacam5 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ceacam5 Mouse Pre-designed siRNA Set A Ceacam5 Mouse Pre-designed siRNA Set A

HY-P991936

*Anti-CEACAM5/CEA/CD66e Antibody (16C3)*	Transmembrane Glycoprotein	Cancer
Anti-CEACAM5/CEA/CD66e Antibody (16C3) is an antibody against human *CEACAM5/CEA/CD66e*. Recommend Isotype Controls:?Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P992350

EBC-129 Antibody	ADC Antibody Transmembrane Glycoprotein	Cancer
EBC-129 Antibody is a specific antibody for the synthetic antibody-drug conjugate (ADC) EBC-129, which specifically targets *CEACAM5* and *CEACAM6* glycosylated at N256. EBC-129 Antibody can be used for the research of pancreatic ductal adenocarcinoma .

HY-P992090

Altumomab	Radionuclide-Drug Conjugates (RDCs) Transmembrane Glycoprotein	Inflammation/Immunology
Altumomab is a anti-huamn monoclonal antibody targeting *CEACAM5/CEA/CD66e* .

HY-P990854

*Anti-CEACAM1/3/5/6/8 Antibody (6G5j)*	Transmembrane Glycoprotein	Cancer
Anti-CEACAM1/3/5/6/8 Antibody (6G5j) is a kind of mouse IgG1 κ chimeric antibody, targeting to human *CEACAM1/3/5/6/8. Anti-CEACAM1/3/5/6/8 Antibody (6G5j) reacts with an antigen epitope shared by human carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 1, 3, 5, 6, and 8. Anti-CEACAM*1/3/5/6/8 Antibody (6G5j) can be used for the detections of western blot, ELISA, immunofluorescence immunohistochemistry and flow cytometry in cancer .

Cat. No.	Product Name	Type

HY-177434

Precemtabart tocentecan Precem-TcT; M 9140	Fluorescent Dye
Precemtabart tocentecan (Precem-TcT; M 9140) is an anti-CEACAM5 (carcinoembryonic antigen-related cell adhesion molecule 5) antibody-drug conjugate (ADC). Precemtabart tocentecan consists of a tumor-specific anti-CEACAM5 monoclonal antibody Precemtabart (HY-P990940), a highly hydrophilic and stable cleavable β-glucuronide linker, and a topoisomerase 1 inhibitor payload Exatecan (HY-13631), and the drug-linker conjugate for ADC is Mal-Gly-PAB-Exatecan-D-glucuronic acid (HY-153179). Precemtabart tocentecan inhibits the growth of CEACAM5-positive cancer cells. Precemtabart tocentecan exhibits significant antitumor activity in CEACAM5-expressing xenograft models. Precemtabart tocentecan can be used for the study of CEACAM5-expressing advanced solid tumors, especially mCRC .

Precemtabart tocentecan

Precem-TcT; M 9140

Fluorescent Dye

Precemtabart tocentecan (Precem-TcT; M 9140) is an anti-CEACAM5 (carcinoembryonic antigen-related cell adhesion molecule 5) antibody-drug conjugate (ADC). Precemtabart tocentecan consists of a tumor-specific anti-CEACAM5 monoclonal antibody Precemtabart (HY-P990940), a highly hydrophilic and stable cleavable β-glucuronide linker, and a topoisomerase 1 inhibitor payload Exatecan (HY-13631), and the drug-linker conjugate for ADC is Mal-Gly-PAB-Exatecan-D-glucuronic acid (HY-153179). Precemtabart tocentecan inhibits the growth of CEACAM5-positive cancer cells. Precemtabart tocentecan exhibits significant antitumor activity in CEACAM5-expressing xenograft models. Precemtabart tocentecan can be used for the study of CEACAM5-expressing advanced solid tumors, especially mCRC .

Cat. No.	Product Name	Target	Research Area	Image

HY-P99054

Tusamitamab SAR-408377; PF-08046050 Antibody; SAR445953 Antibody	Transmembrane Glycoprotein ADC Antibody	Cancer
Tusamitamab is an IgG1 monoclonal antibody that targets *CEACAM5*. Tusamitamab can be used to synthesize ADC Tusamitamab ravtansine (SAR408701) (HY-P99542) .

HY-P99542

Tusamitamab ravtansine SAR-408701; HuMAb2-3-SPDB-DM4	Antibody-Drug Conjugates (ADCs) Microtubule/Tubulin	Cancer
Tusamitamab ravtansine (SAR-408701) is a targeted ADC against tumor cells expressing *CEACAM5, composed of a humanized anti-CEACAM5* monoclonal antibody covalently linked to the potent cytotoxic agent, maytansinoid DM4 (HY-12454), via a cleavable linker. Tusamitamab ravtansine has an average drug-to-antibody ratio (DAR) of 3.8 .

HY-P990940

Precemtabart MBE-748; M-9140 Antibody; MBE-2882 Antibody	Inhibitory Antibodies	Inflammation/Immunology
HY-P990940 is an *CEACAM5*-targeting IgG1κ type human antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001) .

HY-P991060

Cergutuzumab	Transmembrane Glycoprotein	Cancer
Cergutuzumab is a fully human IgG1 antibody that targets carcinoembryonic antigen (CEA, *CEACAM5, CD66e*). Cergutuzumab can be used to form the recombinant protein Cergutuzumab amunaleukin (HY-P99498) .

HY-P991469

AMG-211 MEDI-565	Transmembrane Glycoprotein	Cancer
AMG-211 (MEDI-565)i s a bispecific antibody targeting CD3E and *CEACAM5/CEA/CD66e*. AMG-211 can be used in Gastrointestinal cancer and Solid tumours research .

HY-P991563

*Anti-CEACAM5* Antibody (A5B7)**	Inhibitory Antibodies	Others
Anti-CEACAM5 Antibody (A5B7) is a humanized antibody expressed in CHO cells, targeting *CEACAM5/CEA/CD66e. Anti-CEACAM5* Antibody (A5B7) consists of a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for the Anti-CEACAM5 Antibody (A5B7) can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990853

*Anti-CEACAM5* Antibody (4H11-8)**	Transmembrane Glycoprotein	Cancer
Anti-CEACAM5 Antibody (4H11-8) is a kind of mouse IgG1 κ chimeric antibody, targeting to human *CEACAM5. Anti-CEACAM5* Antibody (4H11-8) reacts with human CEACAM5 (carcinoembryonic antigen-related cell adhesion molecule 5). Anti-CEACAM5 Antibody (4H11-8) can be used for detecting CEACAM5 in cancer.

HY-P990365

*Anti-CEACAM5/CEA/CD66e Antibody*	Inhibitory Antibodies	Inflammation/Immunology
The Anti-CEACAM5/CEA/CD66e Antibody is a humanized antibody expressed in CHO cells, targeting *CEACAM5/CEA/CD66e. The Anti-CEACAM5/CEA/CD66e* Antibody has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for the Anti-CEACAM5/CEA/CD66e Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P991936

*Anti-CEACAM5/CEA/CD66e Antibody (16C3)*	Transmembrane Glycoprotein	Cancer
Anti-CEACAM5/CEA/CD66e Antibody (16C3) is an antibody against human *CEACAM5/CEA/CD66e*. Recommend Isotype Controls:?Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P992350

EBC-129 Antibody	ADC Antibody Transmembrane Glycoprotein	Cancer
EBC-129 Antibody is a specific antibody for the synthetic antibody-drug conjugate (ADC) EBC-129, which specifically targets *CEACAM5* and *CEACAM6* glycosylated at N256. EBC-129 Antibody can be used for the research of pancreatic ductal adenocarcinoma .

HY-P992090

Altumomab	Radionuclide-Drug Conjugates (RDCs) Transmembrane Glycoprotein	Inflammation/Immunology
Altumomab is a anti-huamn monoclonal antibody targeting *CEACAM5/CEA/CD66e* .

HY-P990854

*Anti-CEACAM1/3/5/6/8 Antibody (6G5j)*	Transmembrane Glycoprotein	Cancer
Anti-CEACAM1/3/5/6/8 Antibody (6G5j) is a kind of mouse IgG1 κ chimeric antibody, targeting to human *CEACAM1/3/5/6/8. Anti-CEACAM1/3/5/6/8 Antibody (6G5j) reacts with an antigen epitope shared by human carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 1, 3, 5, 6, and 8. Anti-CEACAM*1/3/5/6/8 Antibody (6G5j) can be used for the detections of western blot, ELISA, immunofluorescence immunohistochemistry and flow cytometry in cancer .

Recombinant Proteins Recommended:

CEACAM-5

Species:	Human (13) Mouse (2) Cynomolgus (2)
Tag:	His (12) Avi (6) Fc (5)
Source:	HEK293 (17)

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P78755

	CEACAM5 Protein, Mouse (HEK293, Fc) CEACAM-5; CD66e; CEA; Meconium antigen 100	Mouse	HEK293
	The CEACAM5 protein is a key cell surface glycoprotein that promotes cell adhesion, signaling, and tumor progression. It interacts with CEACAM6 and other related molecules to support homo- and hetero-sex adhesion. CEACAM5 Protein, Mouse (HEK293, Fc) is the recombinant mouse-derived CEACAM5 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of CEACAM5 Protein, Mouse (HEK293, Fc) is 913 a.a., with molecular weight of 135-180 kDa.

HY-P78756

	CEACAM5 Protein, Mouse (HEK293, His) CEACAM-5; CD66e; CEA; Meconium antigen 100	Mouse	HEK293
	The CEACAM5 protein is a key cell surface glycoprotein that promotes cell adhesion, signaling, and tumor progression. It interacts with CEACAM6 and other related molecules to support homo- and hetero-sex adhesion. CEACAM5 Protein, Mouse (HEK293, His) is the recombinant mouse-derived CEACAM5 protein, expressed by HEK293 , with C-His labeled tag.

HY-P72693

	CEACAM5 Protein, Human (HEK293, Fc) Carcinoembryonic antigen-related cell adhesion molecule 5; CEA; CD66e; CEACAM5	Human	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. CEACAM5 Protein, Human (HEK293, Fc) is the recombinant human-derived CEACAM5 protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P701270

	*FITC-Labeled CEACAM5* Protein, Human (HEK293, Fc)** CEACAM-5; CD66e; CEA; Meconium antigen 100	Human	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. FITC-Labeled CEACAM5 Protein, Human (HEK293, Fc) is the recombinant human-derived FITC-Labeled CEACAM5 protein, expressed by HEK293 , with Fc labeled tag.

HY-P701271

	*FITC-Labeled CEACAM5* Protein, Human (HEK293, His, Avi)** CEACAM-5; CD66e; CEA; Meconium antigen 100	Human	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. FITC-Labeled CEACAM5 Protein, Human (HEK293, His, Avi) is the recombinant human-derived FITC-Labeled CEACAM5 protein, expressed by HEK293 , with His and Avi labeled tag.

HY-P70675

	CEACAM5 Protein, Human (HEK293, His) 1 Publications Verification Carcinoembryonic antigen-related cell adhesion molecule 5; Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e; CEACAM5	Human	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. CEACAM5 Protein, Human (HEK293, His) is the recombinant human-derived CEACAM5 protein, expressed by HEK293 , with C-6*His labeled tag.

HY-P704499

	CEACAM5 Protein, Human (187a.a, HEK293, His) Carcinoembryonic antigen-related cell adhesion molecule 5; Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e; CEACAM5	Human	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. CEACAM5 Protein, Human (187a.a, HEK293, His) is the recombinant human-derived CEACAM5 protein, expressed by HEK293, with C-His labeled tag.

HY-P704497

	*FITC-Labeled CEACAM5* Protein, Human (HEK293, C-His)** Carcinoembryonic antigen-related cell adhesion molecule 5; Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e; CEACAM5	Human	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. FITC-Labeled CEACAM5 Protein, Human (HEK293, C-His) is the recombinant human-derived FITC-Labeled CEACAM5 protein, expressed by HEK293, with C-His labeled tag.

HY-P704498

	CEACAM5 Protein, Human (137a.a, HEK293, Llama Fc) Carcinoembryonic antigen-related cell adhesion molecule 5; Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e; CEACAM5	Human	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. CEACAM5 Protein, Human (137a.a, HEK293, Llama Fc) is the recombinant human-derived CEACAM5 protein, expressed by HEK293, with C-Llama Fc labeled tag.

HY-P76817

	CEACAM5 Protein, Cynomolgus (HEK293, His) Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e	Cynomolgus	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. CEACAM5 Protein, Cynomolgus (HEK293, His) is the recombinant cynomolgus-derived CEACAM5 protein, expressed by HEK293 , with C-His labeled tag.

HY-P75356

	CEACAM5 Protein, Human (HEK293, His, solution) Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e	Human	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. CEACAM5 Protein, Human (HEK293, His, solution) is the recombinant human-derived CEACAM5 protein, expressed by HEK293 , with C-His labeled tag.

HY-P75355

	CEACAM5 Protein, Human (Biotinylated, HEK293, C-His) Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e	Human	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. CEACAM5 Protein, Human (Biotinylated, HEK293, C-His) is the recombinant human-derived CEACAM5 protein, expressed by HEK293 , with N-His, N-GST labeled tag.

HY-P705004

	CEACAM5 Protein, Human (Biotinylated, HEK293, Fc-Avi) Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e	Human	HEK293

HY-P72362

	CEACAM5 Protein, Human (Biotinylated, HEK293, His-Avi) Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e	Human	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. CEACAM5 Protein, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived CEACAM5 protein, expressed by HEK293 , with C-Avi, C-6*His labeled tag.

HY-P705005

	CEACAM5 Protein, Human (Biotinylated, 187a.a, HEK293, His-Avi) Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e	Human	HEK293

HY-P705006

	CEACAM5 Protein, Human (Biotinylated, 83a.a, HEK293, His-Avi) Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e	Human	HEK293

HY-P705137

	CEACAM5 Protein, Cynomolgus (Biotinylated, HEK293, His-Avi) Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e	Cynomolgus	HEK293

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Host:	Mouse (4) Rabbit (1)
Reactivity:	Human (5)
Application:	IHC-P (5) ICC/IF (1) IF-Tissue (2) IHC-F (2) WB (3) ELISA (2)
Isotype:	IgG (2) IgG1 (2)
Conjugation:	Non-conjugated (5) Biotin (6)
Clonality:	Monoclonal (2) Monoclonal Antibody (1) Recombinant (1)
Modification:	Unmodified (3)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P83977

	CEA Antibody (YA3674) CEA; CD66e; DKFZp781M2392; CEACAM5	IHC-P, ELISA	Human
	CEA Antibody (YA3674) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to CEA.

HY-P83977A

	CEA Antibody (YA3674)(PBS only) CEA; CD66e; DKFZp781M2392; CEACAM5	IHC-P, ELISA	Human
	CEA Antibody (YA3674) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to CEA.

HY-P85091

	CEA Antibody (YA4783) CEACAM5; CEA; Carcinoembryonic antigen-related cell adhesion molecule 5; Carcinoembryonic antigen; CEA; Meconium antigen 100; CD antigen CD66e	WB, IHC-P, IHC-F, IF-Tissue	Human
	CEA Antibody (YA4783) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to CEA.

HY-P85091A

	CEA Antibody (YA4783)(PBS only) CEACAM5; CEA; Carcinoembryonic antigen-related cell adhesion molecule 5; Carcinoembryonic antigen; CEA; Meconium antigen 100; CD antigen CD66e	WB, IHC-P, IHC-F, IF-Tissue	Human
	CEA Antibody (YA4783) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to CEA.

HY-P81080

	CEA Antibody (YA917) Carcinoembryonic antigen; Carcinoembryonic antigen related cell adhesion molecule 5; Carcinoembryonic antigen-related cell adhesion molecule 5; CD66e; CD66e antigen; CEACAM5; CEAM5_HUMAN; DKFZp781M2392; Meconium antigen 100.	WB, IHC-P, ICC/IF	Human
	CEA Antibody (YA917) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to CEA.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name		Classification

HY-RS02441

CEACAM5 Human Pre-designed siRNA Set A		siRNAs Human Pre-designed siRNA Sets
CEACAM5 Human Pre-designed siRNA Set A contains three designed siRNAs for CEACAM5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HY-RS17043

Ceacam5 Mouse Pre-designed siRNA Set A		siRNAs Mouse Pre-designed siRNA Sets
Ceacam5 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ceacam5 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inhibitors & Agonists

Fluorescent Dye

Inhibitory Antibodies

Recombinant Proteins

Antibodies

Oligonucleotides